Arcadia Biosciences Cash Flow - Annual (NASDAQ:RKDA)

Add to My Stocks
$6.08 $0.16 (2.7%) RKDA stock closing price Aug 21, 2018 (Closing)

For analyzing any company like Arcadia Biosciences from an investment perspective, its important to check the cash flow statement. While its important to look at the Arcadia Biosciences debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as Arcadia Biosciences revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. This statement can tell if a company is running out of money while still being profitable and is useful in Arcadia Biosciences stock analysis. Arcadia Biosciences had a negative net income cash flow of $-15.7M for the latest 2017. This report is very useful in measuring the short term viability of a company. Arcadia Biosciences saw a inflow of $47.17M from investing activities for 2017.

View details of Arcadia Biosciences cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-----
Net Increase (Decrease) in Assets Liabilities-0.92M--0.05M-1.33M-0.14M
Cash From (used in) Discontinued Operations-----
Other Adjustments Net2.47M1.26M2.52M4.53M3.2M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.07M-0.23M-0.14M-0.14M-0.1M
Acquisition Disposition of Subsidiaires----1.45M-0.5M
Increase (Decrease) in Investments47.25M-5.07M-46.21M--
Other Cash Inflow (Outflow) from Investment Activities-----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--68.58M32.86M-
Issuance (Repayment) of Debt Securities-25M-10.2M-1.15M7.83M
Increase (Decrease) in Bank & Other Borrowings-----
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-1.12M-0.04M-9.92M-1.59M-0.02M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year2.01M23.97M16.57M2.83M5.35M
Cash & Equivalents at Year End9.12M2.01M23.97M16.57M2.83M
All figures in USD. M: Millions of USD, B: Billions of USD.

Arcadia Biosciences stock price history provides insight into historical stock price fluctuations, and Arcadia Biosciences stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Arcadia Biosciences is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Arcadia Biosciences stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Arcadia Biosciences lost $-13.96M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a positive value of $47.17M for RKDA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash flow from financing activities shows the flow of cash between Arcadia Biosciences and its owners and creditors and was $-26.1M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Arcadia Biosciences Cash Flow